New combo therapy aims to tame aggressive sarcoma
NCT ID NCT07342322
First seen Jan 23, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study tests a new treatment plan for adults with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The treatment combines a special type of radiation with an immunotherapy drug and other supportive medicines. The goal is to see if this combination can shrink tumors and control the disease, while carefully tracking any side effects. About 25 people will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA (STS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.